10.3 0.04 (0.39%) | 12-29 14:30 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 12.03 | 1-year : | 14.05 |
Resists | First : | 10.3 | Second : | 12.03 |
Pivot price | 10.26 | |||
Supports | First : | 10.21 | Second : | 10.15 |
MAs | MA(5) : | 10.3 | MA(20) : | 10.25 |
MA(100) : | 10.18 | MA(250) : | 10.05 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 99.8 | D(3) : | 99.8 |
RSI | RSI(14): 86.6 | |||
52-week | High : | 10.67 | Low : | 9.89 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SPK ] has closed below upper band by 23.8%. Bollinger Bands are 42.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 10.31 - 10.36 | 10.36 - 10.4 |
Low: | 10.14 - 10.2 | 10.2 - 10.25 |
Close: | 10.21 - 10.3 | 10.3 - 10.38 |
SPK Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on operating businesses in the telecommunications, media, and technology sectors in Asia. The company was incorporated in 2020 and is based in Shanghai, China.
Thu, 16 Nov 2023
Watkins Advises Searchlight Capital Partners on Acquisition of Integrated Power Services - Latham & Watkins LLP -
Thu, 27 Jul 2023
Roche loses spark for gene therapy, axing hemophilia A candidate from pipeline - Fierce Biotech
Tue, 11 Jul 2023
Norway's SPK selects Mambu and Knowit to support its upcoming housing loan solution - FinTech Futures
Tue, 27 Dec 2022
SPK Acquisition Corp. (SPK) Terminates Varian Bio Deal, Will Liquidate|SPACInsider - SPACInsider
Fri, 01 Apr 2022
Why are SPACs of interest to pharma and biotech? - The Pharma Letter
Tue, 08 Mar 2022
SPAC market shows signs of life, with two DAs. And all the day's news in SPACs. - TheStreet
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 2 (M) |
Shares Float | 0 (M) |
Held by Insiders | 98.2 (%) |
Held by Institutions | 74.7 (%) |
Shares Short | 2 (K) |
Shares Short P.Month | 1 (K) |
EPS | -0.13 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.88 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -79.24 |
PEG Ratio | 0 |
Price to Book value | -11.71 |
Price to Sales | 0 |
Price to Cash Flow | -55.09 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |